Startups
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin, its improved version of the widely used chemotherapeutic agent doxorubicin, and DK049, a novel drug conjugate. CytRx is also expanding its pipeline of oncology candidates at its laboratory facilities in Freiburg, Germany, through its Linker Activated Drug Release technology platform, a discovery engine designed to leverage CytRx's expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies.
Overview
Employees
11-50
Total raised
$40M
Founded date
1985
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 8, 2016 | CytRx Raises $40M Via Term Loan | Los Angeles-based biopharmaceuticals developer CytRx said this morning that it has raised $40M via a long term, loan facility. The financing came from Herculus Technology Growth Capital and Hercules Technology III, L.P. The 48-month term lo... |
Reviews 0
FAQ about CytRx Corporation
When was CytRx Corporation founded?
CytRx Corporation was founded in 1985.
How much funding has CytRx Corporation raised?
CytRx Corporation has raised $40M in total across 1 funding round.
What has the press written about CytRx Corporation?
Parsers VC has collected 2 articles mentioning CytRx Corporation, among them “CytRx Raises $40M Via Term Loan” (Feb 8, 2016).
Is CytRx Corporation still active?
Yes, CytRx Corporation is active; its latest activity on Parsers VC dates from Mar 24, 2021.